Porphyria cutanea tarda in south-east New South Wales

Australasian Journal of Dermatology

Volumn 43, Issue 4, 2002, Pages 285-288

  McCrossin, Ian ^a  

^a NONE   (Australia)

Author keywords

Alcohol; Haemochromatosis; Hepatitis C virus; Oestrogens

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; SEASHORE;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; RETROSPECTIVE STUDIES;

EID: 0036441169     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-0960.2002.00614.x     Document Type: Article

References (17)

1. Bulaj ZT, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee DJ, Edwards CQ, Kushner JP. Haemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000; 95: 1565-71.
2. Bickers DR, Pathak MA, Lim HW. The porphyrias. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds). Fitzpatrick's Dermatology in General Medicine, Vol. 2, 5th edn. New York: McGraw Hill, 1999; 1766-803.
3. Bleasel NR, Varigos GA. Porphyria cutanea tarda. Australas. J. Dermatol. 2000; 41: 197-208.
4. Chuang Ty, Brashear R, Lewis C. Porphyria cutanea tarda and hepatitis C virus: A case-control study and meta-analysis of the literature. J. Am. Acad. Dermatol. 1999; 41: 31-6.
5. Gibson PR, Ratnaike S, Blake D, Sineckas V. Porphyria cutanea tarda and hepatitis C. Med. J. Aust. 1995; 162: 54.
6. Stuart KA, Busfield F, Jazwinska EC, Gibson P, Butterworth LA, Cooksley WG, Powell LW, Crawford HG. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J. Hepatol. 1998; 28: 404-9.
7. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Bisceglie AD, Tattrie C, Tortorelli K, Le Clair P, Mercurio MG, Lambrecht R. Porphyria cutanea tarda, hepatitis C and HFE gene mutations in North America. Hepatology 1998; 27: 1661-9.
8. Sheikh MY, Wright RA, Burruss JB. Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C. Dig. Dis. Sci. 1998; 43: 529-33.
9. Bulaj ZJ, Ajioka RS, Phillips JD, La Salle BA, Jorde LB, Griffen LM, Edwards CA, Kushner JP. Disease-related conditions in relatives of patients with hemochromatosis. N. Engl. J. Med. 2000; 343: 1529-35.
10. Olynyk JK, Cullen D, Aquilia BS, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 1999; 341: 718-24.
11. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al. A novel MUC Class 1-like gene is mutated in patients with hereditary hemochromatosis. Nat. Genet. 1996; 13: 399-408.
12. Tavill AS. Clinical implications of the hemochromatosis gene. N. Engl. J. Med. 1999; 341: 755-7.
13. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and haemochromatosis: At the crossroads. Gastroenterology 1999; 116: 193-207.
14. Bacon BR, Olnyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with haemochromatosis and other liver diseases. Ann. Int. Med. 1999; 130: 953-62.
15. Moirand R, Jouanelle AM, Brissot P, Le Gall JY, Veronique D, Deugnier Y. Phenotypic expression of HFE mutations: A French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology 1999; 116: 372-7.
16. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis CYS282 Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-3.
17. Vautier G, Murray M, Olnyk JK. Hereditary haemochromatosis: Detection and management. Med. J. Aust. 2001; 175: 418-21.